US SB3311 | 2023-2024 | 118th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on November 15 2023 - 25% progression, died in committee
Action: 2024-07-25 - Committee on Banking, Housing, and Urban Affairs. Hearings held.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 15 2023 - 25% progression, died in committee
Action: 2024-07-25 - Committee on Banking, Housing, and Urban Affairs. Hearings held.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to direct the Secretary of Health and Human Services to conduct a demonstration program to test providing preferential treatment under the Medicare, Medicaid, and CHIP programs for certain drugs and biologicals manufactured in the United States.
Title
American Made Pharmaceuticals Act of 2023
Sponsors
Sen. Tina Smith [D-MN] | Sen. Tom Cotton [R-AR] | Sen. Michael Bennet [D-CO] |
History
Date | Chamber | Action |
---|---|---|
2024-07-25 | Senate | Committee on Banking, Housing, and Urban Affairs. Hearings held. |
2023-11-15 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB9321 (Related) 2024-12-17 - Referred to the Subcommittee on Health.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/senate-bill/3311/all-info |
Text | https://www.congress.gov/118/bills/s3311/BILLS-118s3311is.pdf |